Increase in the proportion of highly suppressive tumor-infiltrating Treg cells following TIGIT expression is associated with poor clinical outcomes in patients with hepatocellular carcinoma (HCC) and metastatic melanoma [47,57]. Here, TIGIT is linked to metastatic melanoma.